Abstract:The candidate-gene approach in association studies of polygenic diseases has often yielded conflicting results. In this hospital-based case-control study with 696 white patients newly diagnosed with bladder cancer and 629 unaffected white controls, we applied a multigenic approach to examine the associations with bladder cancer risk of a comprehensive panel of 44 selected polymorphisms in two pathways, DNA repair and cell-cycle control, and to evaluate higher-order gene-gene interactions, using classification and regression tree (CART) analysis. Individually, only XPD Asp312Asn, RAG1 Lys820Arg, and a p53 intronic SNP exhibited statistically significant main effects. However, we found a significant gene-dosage effect for increasing numbers of potential high-risk alleles in DNA-repair and cell-cycle pathways separately and combined. For the nucleotide-excision repair pathway, compared with the referent group (fewer than four adverse alleles), individuals with four (odds ratio [OR] = 1.52, 95% CI 1.05-2.20), five to six (OR = 1.81, 95% CI 1.31-2.50), and seven or more adverse alleles (OR = 2.50, 95% CI 1.69-3.70) had increasingly elevated risks of bladder cancer (P for trend <.001). Each additional adverse allele was associated with a 1.21-fold increase in risk (95% CI 1.12-1.29). For the combined analysis of DNA-repair and cell-cycle SNPs, compared with the referent group (< 13 adverse alleles), the ORs for individuals with 13-15, 16-17, and >= 18 adverse alleles were 1.22 (95% CI 0.84-1.76), 1.57 (95% CI 1.05-2.35), and 1.77 (95% CI 1.19-2.63), respectively (P for trend = .002). Each additional high-risk allele was associated with a 1.07-fold significant increase in risk. In addition, we found that smoking had a significant multiplicative interaction with SNPs in the combined DNA-repair and cell-cycle-control pathways (P < .01). All genetic effects were evident only in "ever smokers" (persons who had smoked >= 100 cigarettes) and not in "never smokers." A cross-validation statistical method developed in this study confirmed the above observations. CART analysis revealed potential higher-order gene-gene and gene-smoking interactions and categorized a few higher-risk subgroups for bladder cancer. Moreover, subgroups identified with higher cancer risk also exhibited higher levels of induced genetic damage than did subgroups with lower risk. There was a significant trend of higher numbers of bleomycin- and benzo[a]pyrene diol-epoxide (BPDE)-induced chromatid breaks (by mutagen-sensitivity assay) and DNA damage ( by comet assay) for individuals in higher-risk subgroups among cases of bladder cancer in smokers. The P for the trend was .0348 for bleomycin- induced chromosome breaks, .0036 for BPDE-induced chromosome breaks, and .0397 for BPDE-induced DNA damage, indicating that these higher-order gene-gene and gene-smoking interactions included SNPs that modulated repair and resulted in diminished DNA-repair capacity. Thus, genotype/phenotype analyses support findings from CART analyses. This is the first comprehensive study to use a multigenic analysis for bladder cancer, and the data suggest that individuals with a higher number of genetic variations in DNA-repair and cell-cycle control genes are at an increased risk for bladder cancer, confirming the importance of taking a multigenic pathway-based approach to risk assessment.

Prospective Analysis Of Dna Damage And Repair Markers Of Lung Cancer Risk From The Prostate, Lung, Colorectal And Ovarian (Plco) Cancer Screening Trial

[Correlation of Initial DNA Damage Detected by Alkaline Comet Assay and Clinical Endpoints in Lung Cancer Patients].

Cell Cycle Checkpoints, DNA Damage/repair, and Lung Cancer Risk.

Investigating the genetic instability in the peripheral lymphocytes of 36 untreated lung cancer patients with comet assay and micronucleus assay.

[Relationship Between Polymorphisms of DNA Repair Gene XRCC3 and Susceptibility to Lung Cancer].

Gamma-radiation-induced Single Cell DNA Damage As a Measure of Susceptibility to Lung Cancer: a Preliminary Report.

Relationship Between Polymorphisms of DNA Repair Gene ERCC1 and Susceptibility to Lung Cancer

Risk assessment of renal cell carcinoma using alkaline comet assay.

Genetic Instability in Bladder Cancer Assessed by the Comet Assay

Predictors of Esophageal Cancer Risk: Assessment of Susceptibility to DNA Damage Using Comet Assay.

The Association Between Polymorphisms in the DNA Nucleotide Excision Repair Genes and RRM1 Gene and Lung Cancer Risk.

Pooled Analysis of Mitochondrial DNA Copy Number and Lung Cancer Risk in Three Prospective Studies

Abstract A1: Comprehensive Analyses of DNA Repair Pathways, Smoking, and Bladder Cancer Risk in Los Angeles and Shanghai

Using Cg05575921 methylation to predict lung cancer risk: a potentially bias-free precision epigenetics approach

Data from An Expanded Risk Prediction Model for Lung Cancer

Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck.

In Vitro Benzo[a]pyrene Diol Epoxide-Induced DNA Damage and Chromosomal Aberrations in Primary Lymphocytes, Smoking, and Risk of Squamous Cell Carcinoma of the Head and Neck.

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer

Investigation on potential associations of oxidatively generated DNA/RNA damage with lung, colorectal, breast, prostate and total cancer incidence

Polymorphisms in DNA Base Excision Repair Genes ADPRT and XRCC1 and Risk of Lung Cancer

Bladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle–Control Genes